Esraa Atef: Understanding Oocyte Morphology and ICSI Outcomes
Esraa Atef, Embryologist at City Hospital, shared a post on LinkedIn:
“Understanding Oocyte Morphology in ICSI Failure
Human oocytes show wide morphological variation, but how much do these features really explain fertilization failure?
A recent study analyzed 142 human oocytes that failed to cleave after ICSI, focusing on detailed morphometric and cytoplasmic characteristics such as:
- Oocyte cytoplasmic diameter
- Zona pellucida thickness
- Perivitelline space (PVS) size
- First polar body (PBI) size
- Cytoplasmic granularity patterns and abnormalities (refractile bodies, sER aggregates, vacuoles)
Key findings:
- The majority of non-cleaved oocytes displayed morphological features commonly seen in the general oocyte population.
- Cytoplasmic granularity patterns varied, with fine and dispersed granulation being the most frequent.
- A significant inverse correlation was observed between oocyte cytoplasmic diameter and PVS size.
- Importantly, morphology alone was not sufficient to explain cleavage failure after ICSI.
Takeaway:
While oocyte morphology remains an essential assessment tool in IVF labs, fertilization and early embryo development depend on more complex molecular and cellular mechanisms beyond what we can see under the microscope.
Paper: Morphologic Features and Morphometric Measurements of Human Oocytes That Failed to Cleave after Intracytoplasmic Sperm Injection(ICSI)
This figure shows: Polar body variations, including regular polar body (PB) (a), fragmented PB (b), double polar bodies (c), and giant PB (d); cytoplasmic granulation patterns: fine (e), dispersed (f), central (g), and uneven (h); cytoplasmic abnormalities: refractile bodies (arrows) (i), smooth endoplasmic reticulum (sER) aggregates (asterisks) (j), vacuoles (arrow head) (k), and dark cytoplasm (l).”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 5, 2026, 01:38Hematopoietic X Chromosome Loss May Offer New Insight Into Ovarian Reserve – RBMO
-
Jun 4, 2026, 17:09ESHRE SIG Endometriosis and Endometrial Disorders Launches New Podcast Episode
-
Jun 4, 2026, 17:04June is Uterine Cancer Awareness Month – Foundation for Women’s Cancer
-
Jun 4, 2026, 16:58Giuseppe Caruso: ADC-opoly in endometrial and cervical cancer: Expanding the Board
-
Jun 4, 2026, 16:50Sergio Haimovich: Good Practice Recommendations on Terminology, Classification, and Diagnosis of Adenomyosis
-
Jun 4, 2026, 16:44Richard Flint: Running to Spread Awareness For Antiphospholipid Syndrome
-
Jun 4, 2026, 16:37Karen Synesiou: What Happens to Frozen Embryos, Eggs, and Sperm When Intended Parents Disappear
-
Jun 4, 2026, 16:30Eric Lameignere: The Impact of Sperm Epigenetics on ICSI Outcomes
-
Jun 4, 2026, 16:23Lupus Anticoagulants: A Review of Current Guidelines and Laboratory Practices – Stago